🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This study aims to evaluate the efficacy and safety of QLS31905 and/or QL17...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-06-30
Trial ID
NCT06446388
Treatments Being Tested
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
This study aims to validate the efficacy and safety of GP/GEMOX combined wi...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2024-09-01
Trial ID
NCT06718257
This phase II trial studies the effect of ascorbic acid and combination che...
Status
Recruiting
Location
Mayo Clinic Health Systems-Mankato
Start Date
2018-03-23
Trial ID
NCT03418038
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
This is an open-label study. This means that people in this study and clini...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2022-06-08
Trial ID
NCT05382559
The purpose of this clinical trial is to investigate whether the inclusion ...
Status
Not Yet Recruiting
Location
Zhongshan Hospital
Start Date
2024-07
Trial ID
NCT06502080
The main objective of this trial is to evaluate the activity of pamiparib p...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-05
Trial ID
NCT04796454
Treatments Being Tested
This is a randomized phase 2 trial of gemcitabine + carboplatin + nivolumab...
Status
Completed
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2018-05-10
Trial ID
NCT03451331
Treatments Being Tested